(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.

Dick’s Projects Sales Growth at Namesake Stores, Foot Locker
14:01

Nvidia Invests $2 Billion in Nebius for New Data Center Deal
27:35

Ackman’s Pershing Square Seeks Up to $10 Billion in NYSE IPO
17:40